{"id":"https://openalex.org/W2017201029","doi":"https://doi.org/10.2337/diacare.26.10.2835","title":"Effects of 3 Months of Continuous Subcutaneous Administration of Glucagon-Like Peptide 1 in Elderly Patients With Type 2 Diabetes","display_name":"Effects of 3 Months of Continuous Subcutaneous Administration of Glucagon-Like Peptide 1 in Elderly Patients With Type 2 Diabetes","alternate_titles":[],"publication_year":2003,"publication_date":"2003-10-01","ids":{"openalex":"https://openalex.org/W2017201029","doi":"https://doi.org/10.2337/diacare.26.10.2835","mag":"2017201029","pmid":"https://pubmed.ncbi.nlm.nih.gov/14514588"},"language":"en","primary_location":{"id":"doi:10.2337/diacare.26.10.2835","doi":"https://doi.org/10.2337/diacare.26.10.2835","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diacare.26.10.2835","pdf_url":"https://diabetesjournals.org/care/article-pdf/26/10/2835/590746/dc1003002835.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2017201029"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://diabetesjournals.org/care/article-pdf/26/10/2835/590746/dc1003002835.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046238445","display_name":"Graydon S. Meneilly","orcid":"https://orcid.org/0000-0002-2442-5260","observed_orcids":["https://orcid.org/0000-0002-2442-5260"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Graydon S. Meneilly","raw_affiliation_strings":["Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056649584","display_name":"Nigel H. Greig","orcid":"https://orcid.org/0000-0002-3032-1468","observed_orcids":["https://orcid.org/0000-0002-3032-1468"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nigel Greig","raw_affiliation_strings":["National Institute on Aging, National Institutes of Health, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Aging, National Institutes of Health, Baltimore, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014750217","display_name":"Hugh D. Tildesley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hugh Tildesley","raw_affiliation_strings":["Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034913449","display_name":"Joel Francis Habener","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1344073410","display_name":"Howard Hughes Medical Institute","ror":"https://ror.org/006w34k90","country_code":"US","type":"facility","lineage":["https://openalex.org/I1344073410"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joel F. Habener","raw_affiliation_strings":["Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts","Laboratory of Molecular Endocrinology, Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Laboratory of Molecular Endocrinology, Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1344073410","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000777749","display_name":"Josephine Mary Egan","orcid":"https://orcid.org/0000-0002-8945-0053","observed_orcids":["https://orcid.org/0000-0002-8945-0053"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Josephine M. Egan","raw_affiliation_strings":["National Institute on Aging, National Institutes of Health, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Aging, National Institutes of Health, Baltimore, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007270622","display_name":"Dariush Elahi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Dariush Elahi","raw_affiliation_strings":["Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5007270622"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"],"apc_list":null,"apc_paid":null,"fwci":5.2075,"has_fulltext":true,"cited_by_count":105,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96327151,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"26","issue":"10","first_page":"2835","last_page":"2841"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.9639999866485596},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9639999866485596},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9879999756813049},{"id":"https://openalex.org/keywords/continuous-subcutaneous-infusion","display_name":"continuous subcutaneous infusion","score":0.9679999947547913},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.6470000147819519},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9359999895095825},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9359999895095825},{"id":"https://openalex.org/keywords/glucose-stimulated-insulin-secretion","display_name":"glucose-stimulated insulin secretion","score":0.8489999771118164},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.8410000205039978},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.546999990940094},{"id":"https://openalex.org/keywords/ghrelin","display_name":"ghrelin","score":0.8970000147819519}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.935776948928833},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7706218957901001},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6951743364334106},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6688576340675354},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6373339295387268},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6112947463989258},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.5153902769088745},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.4311390519142151},{"id":"https://openalex.org/C2779357093","wikidata":"https://www.wikidata.org/wiki/Q422269","display_name":"Ghrelin","level":3,"score":0.4298367202281952},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.41751521825790405},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.38637131452560425}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002096","descriptor_name":"C-Peptide","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004343","descriptor_name":"Drug Implants","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005215","descriptor_name":"Fasting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005230","descriptor_name":"Fatty Acids, Nonesterified","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005934","descriptor_name":"Glucagon","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005934","descriptor_name":"Glucagon","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011498","descriptor_name":"Protein Precursors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011498","descriptor_name":"Protein Precursors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2337/diacare.26.10.2835","doi":"https://doi.org/10.2337/diacare.26.10.2835","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diacare.26.10.2835","pdf_url":"https://diabetesjournals.org/care/article-pdf/26/10/2835/590746/dc1003002835.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmid:14514588","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14514588","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Clinical Trial"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.945.495","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.945.495","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://care.diabetesjournals.org/content/diacare/26/10/2835.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.2337/diacare.26.10.2835","doi":"https://doi.org/10.2337/diacare.26.10.2835","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diacare.26.10.2835","pdf_url":"https://diabetesjournals.org/care/article-pdf/26/10/2835/590746/dc1003002835.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G4424937727","display_name":null,"funder_award_id":"DK-98-02","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G5242162727","display_name":null,"funder_award_id":"00599","funder_id":"https://openalex.org/F4320332505","funder_display_name":"U.S. Public Health Service"}],"funders":[{"id":"https://openalex.org/F4320313570","display_name":"Boston Area Diabetes Endocrinology Research Center","ror":"https://ror.org/00bfqs307"},{"id":"https://openalex.org/F4320323180","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20"},{"id":"https://openalex.org/F4320323641","display_name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","ror":"https://ror.org/044gwpv05"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332505","display_name":"U.S. Public Health Service","ror":"https://ror.org/05xf94514"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2017201029.pdf","grobid_xml":"https://content.openalex.org/works/W2017201029.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1748571508","https://openalex.org/W1905803407","https://openalex.org/W1975756049","https://openalex.org/W1980130009","https://openalex.org/W2006984980","https://openalex.org/W2012681547","https://openalex.org/W2017518223","https://openalex.org/W2048352852","https://openalex.org/W2056934377","https://openalex.org/W2073099528","https://openalex.org/W2073996229","https://openalex.org/W2074956966","https://openalex.org/W2089304685","https://openalex.org/W2092745778","https://openalex.org/W2096716906","https://openalex.org/W2100629874","https://openalex.org/W2103960782","https://openalex.org/W2122879720","https://openalex.org/W2139538720","https://openalex.org/W2140137473","https://openalex.org/W2142877036","https://openalex.org/W2143014102","https://openalex.org/W2146400000","https://openalex.org/W2156374993","https://openalex.org/W2158822657","https://openalex.org/W2161075296","https://openalex.org/W2161923520","https://openalex.org/W2168588540","https://openalex.org/W2335958328","https://openalex.org/W2337454357","https://openalex.org/W3141782761","https://openalex.org/W4211101627"],"related_works":["https://openalex.org/W2143014102","https://openalex.org/W2006984980","https://openalex.org/W2139538720","https://openalex.org/W1508479863","https://openalex.org/W2055987651","https://openalex.org/W1980130009","https://openalex.org/W2160757033","https://openalex.org/W2364726207","https://openalex.org/W2001864893"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Glucagon-like":[1],"peptide":[2],"1":[3,76,89,94,202],"(GLP-1)":[4],"is":[5,286],"an":[6],"insulinotropic":[7],"gut":[8],"hormone":[9],"that,":[10],"when":[11],"given":[12],"exogenously,":[13],"may":[14],"be":[15],"a":[16,28,188,276,287],"useful":[17],"agent":[18],"in":[19,39,152,164,180,209],"the":[20,33,198,210,260,274],"treatment":[21,185,256],"of":[22,37,49,190,194,214,254,273],"type":[23,53],"2":[24,54,71],"diabetes.":[25],"We":[26],"conducted":[27],"3-month":[29],"trial":[30],"to":[31,155,160],"determine":[32],"efficacy":[34],"and":[35,83,135,147,162,174,200,232],"safety":[36],"GLP-1":[38,101,211,215,255,284],"elderly":[40,292],"diabetic":[41,293],"patients.":[42,294],"RESEARCH":[43],"DESIGN":[44],"AND":[45],"METHODS:":[46],"A":[47,283],"total":[48,189],"16":[50],"patients":[51,67,85],"with":[52,60],"diabetes":[55],"who":[56],"were":[57,64,145,168,177],"being":[58],"treated":[59],"oral":[61],"hypoglycemic":[62,98,139],"agents":[63],"enrolled.":[65],"Eight":[66],"(aged":[68,86],"75":[69],"+/-":[70,75,88,93,222,226,238,242],"years,":[72,90],"BMI":[73,91],"27":[74,92],"kg/m(2))":[77],"remained":[78],"on":[79,259],"usual":[80,184],"glucose-lowering":[81],"therapy":[82],"eight":[84],"73":[87],"kg/m(2)),":[95],"after":[96],"discontinuing":[97],"medications,":[99],"received":[100],"delivered":[102],"by":[103],"continuous":[104],"subcutaneous":[105],"infusion":[106],"for":[107,291],"12":[108],"weeks.":[109],"The":[110,141,183],"maximum":[111],"dose":[112],"was":[113,207,257,279],"120":[114],"pmol":[115],"x":[116,245,247],"kg(-1).":[117],"h(-1).":[118],"Patients":[119],"recorded":[120,208],"their":[121],"capillary":[122],"blood":[123],"glucose":[124,234],"(CBG)":[125],"levels":[126,167,172,268],"(four":[127],"times":[128],"per":[129,133],"day,":[130],"3":[131],"days":[132],"week)":[134],"whenever":[136],"they":[137],"perceived":[138],"symptoms.":[140],"primary":[142],"end":[143],"points":[144],"HbA(1c)":[146,171],"CBG":[148,192],"determinations.":[149],"Additionally,":[150],"changes":[151,163],"beta-cell":[153],"sensitivity":[154,159],"glucose,":[156],"peripheral":[157],"tissue":[158],"insulin,":[161],"plasma":[165,262,266],"ghrelin":[166,263,267],"examined.":[169],"RESULTS:":[170],"(7.1%)":[173],"body":[175],"weight":[176],"equally":[178],"maintained":[179],"both":[181,271],"groups.":[182],"group":[186],"had":[187],"87":[191],"measurements":[193],"<or=3.6":[195],"mmol/l":[196],"during":[197,270],"study,":[199],"only":[201],"such":[203],"measurement":[204],"(3.5":[205],"mmol/l)":[206],"group.":[212],"Infusion":[213],"enhanced":[216],"glucose-induced":[217],"insulin":[218],"secretion":[219],"(pre:":[220,236],"119":[221],"21;":[223],"post:":[224,240],"202":[225],"51":[227],"pmol/l;":[228],"P":[229,249],"<":[230,250],"0.05)":[231],"insulin-mediated":[233],"disposal":[235],"29.8":[237],"3.3;":[239],"35.9":[241],"2.3":[243],"micromol":[244],"kg(-1":[246],"min(-1);":[248],"0.01).":[251],"No":[252],"effect":[253,278],"seen":[258],"fasting":[261],"levels.":[264],"Although":[265],"decreased":[269],"portions":[272],"clamp,":[275],"drug":[277],"not":[280],"present.":[281],"CONCLUSIONS:":[282],"compound":[285],"promising":[288],"therapeutic":[289],"option":[290]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2017201029","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
